SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001601830-24-000041
Filing Date
2024-04-23
Accepted
2024-04-23 17:16:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A rxrx_proxystatement2024-ad.htm DEFA14A 12202
2 a2024notice_pagex1.jpg GRAPHIC 1208170
3 a2024notice_pagex2.jpg GRAPHIC 618870
  Complete submission text file 0001601830-24-000041.txt   2527363
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40323 | Film No.: 24865884
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)